Laura Dillon

Company: Parthenon Therapeutics

Job title: Head of Translational Biomarkers

Seminars:

Characterization of Immune Excluded Tumors by Multiplex Immunofluorescence for Precision Oncology applications 11:00 am

• Understanding how the spatial relationship between immune cells and the tumor epithelium vs tumor associated stroma is key to reviewing immune exclusion and its relationship to CPI therapy resistance • Thoughtful mIF panel design and reagent validation are necessary to enable interpretation of mIF output • Novel methods are needed to better characterize the…Read more

day: Conference Agenda